Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This will be a randomized, controlled pilot trial of patients with histological documentation
of primary colon or rectal adenocarcinoma with resectable cancer, who have not received any
treatments for cancer. If patient is a candidate for surgical resection, with no planned
neoadjuvant chemotherapy, then the patient is eligible. All eligible subjects will be
consented prior to surgery.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio